TMCI
TREACE MEDICAL CONCEPTS, INC.
Key Financials
Operating Income
$-54154000
↑ 2.8%
Gross Profit
$169.8M
↑ 0.9%
Revenue
$212.7M
↑ 1.6%
Net Income
$-59002000
↓ 5.8%
Shareholders' Equity
$87.3M
↓ 22.6%
Total Liabilities
$103.2M
↓ 0.9%
EPS (Diluted)
$-0.93
↓ 3.3%
Total Assets
$190.6M
↓ 12.2%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| 4/A | 6/12/2026 | View on SEC |
| 4 | 6/11/2026 | View on SEC |
| 4 | 6/1/2026 | View on SEC |
| 4 | 5/28/2026 | View on SEC |
| 8-K | 5/20/2026 | View on SEC |
| 4 | 5/19/2026 | View on SEC |
| 4 | 5/19/2026 | View on SEC |
| 4 | 5/19/2026 | View on SEC |
| 4 | 5/19/2026 | View on SEC |
| 4 | 5/19/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | TMCI |
| Company Name | TREACE MEDICAL CONCEPTS, INC. |
| CIK | 1630627 |
| Sector | Surgical & Medical Instruments & Apparatus |
| Industry | Accelerated filer |
| Exchange | Nasdaq |
| SIC Code | 3841 |
| SIC Description | Surgical & Medical Instruments & Apparatus |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | FL |
| Phone | (904) 373-5940 |